6097 POSTER Ciclosporin in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer – Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification
Gary Middleton(University Hospitals Birmingham NHS Foundation Trust), Michel Seymour(University of Leeds), Ian Chau(Royal Marsden NHS Foundation Trust), C Olivier, Sarah Brown(University of Leeds), Homer C. Marshall, Tim Maughan(University of Liverpool), Jonathan Wadsley(Weston Park Cancer Centre), Stephen J. Gwyther(East Surrey Hospital), Susan D. Richman(University of Leeds)
Cited by 6
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k